NATALIA DE LAS
HERAS JIMÉNEZ
Profesora titular de universidad
![Foto de NATALIA DE LAS](/img/nophoto.png)
![Foto de Hospital de Jerez](/img/noimage_org.png)
Hospital de Jerez
Jerez, EspañaHospital de Jerez-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2023
2022
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2017
-
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
European Journal of Haematology, Vol. 98, Núm. 2, pp. 142-148
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433